Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-08 2:11 pm Purchase |
2025-06-16 | 13G | Aptevo Therapeutics Inc. APVO |
YA II PN, Ltd. | 357,842 9.990% |
357,842 (New Position) |
Filing History |
| 2025-06-25 4:38 pm Unchanged |
2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-06-25 4:30 pm Purchase |
2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO |
BIGGER CAPITAL FUND L P | 285,000 9.950% |
275,000 (+2750.00%) |
Filing History |
| 2025-06-23 4:08 pm Purchase |
2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 285,000 9.950% |
265,000 (+1325.00%) |
Filing History |
| 2025-06-23 4:07 pm Purchase |
2025-04-26 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 20,000 0.700% |
20,000 (New Position) |
Filing History |
| 2025-04-25 4:07 pm Unchanged |
2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-04-25 4:05 pm Purchase |
2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 21,050 7.590% |
7,200 (+51.99%) |
Filing History |
| 2025-04-25 4:01 pm Purchase |
2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 13,850 4.990% |
3,850 (+38.50%) |
Filing History |
| 2025-04-10 10:14 am Purchase |
2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO |
CVI Investments, Inc. | 10,000 6.200% |
10,000 (New Position) |
Filing History |
| 2025-04-09 5:31 pm Unchanged |
2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-04-08 8:00 pm Purchase |
2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO |
BIGGER CAPITAL FUND L P | 10,000 6.200% |
10,000 (New Position) |
Filing History |
| 2025-04-07 4:51 pm Purchase |
2025-04-02 | 13G | Aptevo Therapeutics Inc. APVO |
L1 Capital Global Opportunities Master Fund, Ltd. | 10,000 6.210% |
10,000 (New Position) |
Filing History |
| 2025-02-10 6:58 pm Unchanged |
2024-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Hudson Bay Capital Management LP | 3,830 4.990% |
0 (Unchanged) |
Filing History |
| 2025-02-10 4:24 pm Purchase |
2024-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Hudson Bay Capital Management LP | 3,830 4.990% |
3,830 (New Position) |
Filing History |
| 2024-11-14 3:45 pm Purchase |
2024-09-30 | 13G | Aptevo Therapeutics Inc. APVO |
ARMISTICE CAPITAL LLC | 1,106 4.990% |
1,106 (New Position) |
Filing History |
| 2024-11-08 2:57 pm Purchase |
2024-09-30 | 13G | Aptevo Therapeutics Inc. APVO |
Hudson Bay Capital Management LP | 1,264 6.960% |
1,264 (New Position) |
Filing History |
| 2024-02-14 3:24 pm Purchase |
2023-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
ARMISTICE CAPITAL LLC | 53 9.990% |
53 (New Position) |
Filing History |
| 2023-02-14 10:15 am Sale |
2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
RTW INVESTMENTS LP | 0 0.000% |
-9 (Position Closed) |
Filing History |
| 2022-02-10 3:18 pm Sale |
2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
RENAISSANCE TECHNOLOGIES LLC | 2 1.400% |
-6 (-73.00%) |
Filing History |
| 2021-11-26 1:00 pm Sale |
2021-11-23 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 0 0.000% |
-28 (Position Closed) |
Filing History |